Close

Cyclo Therapeutics Presents Positive Data from Clinical Development Program for Lead Candidate, Trappsol® Cyclo™, at WORLDSymposium 2021

Go back to Cyclo Therapeutics Presents Positive Data from Clinical Development Program for Lead Candidate, Trappsol® Cyclo™, at WORLDSymposium 2021
(NASDAQ: CYTH) Delayed: 1.29 --0 (-0%)
Previous Close $1.29    52 Week High
Open $1.29    52 Week Low
Day High $1.29    P/E N/A 
Day Low $1.29    EPS
Volume 16